Titan Pharmaceuticals
TTNP
#10769
Rank
NZ$10.8 M
Marketcap
NZ$8.13
Share price
-3.76%
Change (1 day)
24.86%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -NZ$4.73 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$8.3 Million, an increase over its 2023 earnings that were of -NZ$9.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$4.73 Million-43.01%
2024 -NZ$8.3 Million-15.5%
2023 -NZ$9.82 Million-45.43%
2022 -NZ$17.99 Million16.29%
2021 -NZ$15.47 Million-907.36%
2020 NZ$1.91 M-106.6%
2019 -NZ$29.01 Million82.4%
2018 -NZ$15.91 Million-36.93%
2017 -NZ$25.22 Million-378.62%
2016 NZ$9.05 M-145.53%
2015 -NZ$19.88 Million369.37%
2014 -NZ$4.24 Million-125.9%
2013 NZ$16.35 M-177.74%
2012 -NZ$21.04 Million13.59%
2011 -NZ$18.52 Million74.37%
2010 -NZ$10.62 Million3.61%
2009 -NZ$10.25 Million
2007 -NZ$32.49 Million12.08%
2006 -NZ$28.99 Million-28.65%
2005 -NZ$40.63 Million-10.03%
2004 -NZ$45.16 Million-6.08%
2003 -NZ$48.08 Million-14.76%
2002 -NZ$56.41 Million32.52%
2001 -NZ$42.57 Million27.55%
2000 -NZ$33.38 Million62.5%
1999 -NZ$20.54 Million4.04%
1998 -NZ$19.75 Million49.33%
1997 -NZ$13.22 Million-27.88%
1996 -NZ$18.34 Million13.04%
1995 -NZ$16.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.78 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.81 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-NZ$0.22 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.14 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$21.16 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.51 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA